Centrica PLC (CPYYF) reports strong EBITDA and dividend growth while navigating market volatility and investment opportunities.

Physitrack's Board of Directors has approved the intention to implement a share buyback program (the "SBB"), subject to lender consent and prevailing market conditions. LONDON, GB / ACCESS Newswire / ...

Novo Nordisk advanced coramitug into the Phase III CLEOPATTRA trial, evaluating 1,280 patients with amyloid transthyretin cardiomyopathy or ATTR-CM. This decision was informed by results from their ...

Study to be conducted by PharmaLegacy, a leading Contract Research Organization The scientific rationale for evaluating ...

Tronox Holdings plc (NYSE:TROX) Q4 2025 Earnings Call Transcript February 19, 2026 Operator: Good morning, ladies and ...

Aptiv PLC ( APTV) Barclays 43rd Annual Industrial Select Conference February 18, 2026 8:05 AM EST ...

Hosted at the Hong Kong Convention and Exhibition Centre and co-organised by MCIT, the Saudi Federation for Cybersecurity ...

BAE Systems plc (OTC:BAESY) Q4 2025 Earnings Call Transcript February 18, 2026 BAE Systems plc misses on earnings expectations. Reported EPS is $2.13 EPS, expectations were $2.21. Operator: Good day, ...

Aesthetic Record selected as a leading aesthetics EMR and practice management partner due to its commitment to technology innovation, operational efficiency, and supporting thousands of aesthetic prac ...

Medtronic plc announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has granted reimbursement approval fo ...

Funding to support the execution of a Phase 2 proof-of-concept trial of HER-096 in Parkinson's disease, following completion of study preparations Espoo, Finland, 19 February 2026: Herantis Pharma ...

DermFx selected as a leading regional med spa partner due to its commitment to exceptional patient care, aesthetic innovation, and excellence across Southern California practices ...